Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suzanne M Dintzis

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Advances in Anatomic Pathology|January 23, 2018
Disclosure of Harmful Medical Error to Patients: A Review With Recommendations for PathologistsYael K Heher, Suzanne M Dintzis
American Journal of Clinical Pathology|March 18, 2009
Disclosing harmful pathology errors to patientsSuzanne M Dintzis, Thomas H Gallagher
American Journal of Clinical Pathology|November 19, 2011
Frequency of HER2 heterogeneity by fluorescence in situ hybridization according to CAP expert panel recommendations: time for a new look at how to report heterogeneityKimberly H Allison, Suzanne M Dintzis, Rodney A Schmidt
Archives of Pathology & Laboratory Medicine|June 4, 2021
Medical Education in Pathology: General Concepts and Strategies for ImplementationLisa K Koch, Oliver H Chang, Suzanne M Dintzis
Theranostics|June 3, 2020
Quantitative chemical imaging of breast calcifications in association with neoplastic processesKseniya S Shin, Mint Laohajaratsang, Shuaiqian Men, et al.
Annals of Surgical Oncology|August 24, 2011
Lobular in-situ neoplasia on breast core needle biopsy: imaging indication and pathologic extent can identify which patients require excisional biopsyMara H Rendi, Suzanne M Dintzis, Constance D Lehman, et al.
American Journal of Clinical Pathology|July 28, 2010
Achieving 95% cross-methodological concordance in HER2 testing: causes and implications of discordant casesErin E Grimm, Rodney A Schmidt, Paul E Swanson, et al.
Archives of Pathology & Laboratory Medicine|September 10, 2016
Surgical Specimen Management: A Descriptive Study of 648 Adverse Events and Near MissesVictoria M Steelman, Tamara L Williams, Marilyn K Szekendi, et al.
Archives of Pathology & Laboratory Medicine|April 1, 2017
Pathologists' Perspectives on Disclosing Harmful Pathology ErrorSuzanne M Dintzis, Emily K Clennon, Carolyn D Prouty, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 26, 2018
Unexpected PAX8 Immunoreactivity in Metastatic High-grade Breast CancerMark R Kilgore, Dustin E Bosch, Kathi H Adamson, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Advances in Anatomic Pathology|January 23, 2018
Disclosure of Harmful Medical Error to Patients: A Review With Recommendations for PathologistsYael K Heher, Suzanne M Dintzis
American Journal of Clinical Pathology|March 18, 2009
Disclosing harmful pathology errors to patientsSuzanne M Dintzis, Thomas H Gallagher
American Journal of Clinical Pathology|November 19, 2011
Frequency of HER2 heterogeneity by fluorescence in situ hybridization according to CAP expert panel recommendations: time for a new look at how to report heterogeneityKimberly H Allison, Suzanne M Dintzis, Rodney A Schmidt
Archives of Pathology & Laboratory Medicine|June 4, 2021
Medical Education in Pathology: General Concepts and Strategies for ImplementationLisa K Koch, Oliver H Chang, Suzanne M Dintzis
Theranostics|June 3, 2020
Quantitative chemical imaging of breast calcifications in association with neoplastic processesKseniya S Shin, Mint Laohajaratsang, Shuaiqian Men, et al.
Annals of Surgical Oncology|August 24, 2011
Lobular in-situ neoplasia on breast core needle biopsy: imaging indication and pathologic extent can identify which patients require excisional biopsyMara H Rendi, Suzanne M Dintzis, Constance D Lehman, et al.
American Journal of Clinical Pathology|July 28, 2010
Achieving 95% cross-methodological concordance in HER2 testing: causes and implications of discordant casesErin E Grimm, Rodney A Schmidt, Paul E Swanson, et al.
Archives of Pathology & Laboratory Medicine|September 10, 2016
Surgical Specimen Management: A Descriptive Study of 648 Adverse Events and Near MissesVictoria M Steelman, Tamara L Williams, Marilyn K Szekendi, et al.
Archives of Pathology & Laboratory Medicine|April 1, 2017
Pathologists' Perspectives on Disclosing Harmful Pathology ErrorSuzanne M Dintzis, Emily K Clennon, Carolyn D Prouty, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 26, 2018
Unexpected PAX8 Immunoreactivity in Metastatic High-grade Breast CancerMark R Kilgore, Dustin E Bosch, Kathi H Adamson, et al.
Pageof 3